PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Physiology, Faculty of Medicine, INCLIVA Biomedical Research Institute, University of Valencia, Av. Blasco Ibáñez, 15, 46010, Valencia, Spain. fabian.sanchis@uv.es.\', \'Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA. fabian.sanchis@uv.es.\', \'John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA.\', \'Department of Physiology, Faculty of Medicine, INCLIVA Biomedical Research Institute, University of Valencia, Av. Blasco Ibáñez, 15, 46010, Valencia, Spain.\', \'Institute of Clinical Medicine, Department of Medicine, University of Eastern Finland, Kuopio, Finland.\', \'Department of Medicine, Central Finland Health Care District, Jyvaskyla, Finland.\', \'Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40256-020-00429-7
?:hasPublicationType
?:journal
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
is ?:pmid of
?:pmid
?:pmid
  • 32737841
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32737841>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32737841>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all